glioblastoma multiforme

skiing bumpy black diamond

Biotech

Black Diamond runs into rocky terrain, trims 30% of workforce

Black Diamond is closing down at least one run at a precision oncology med and cutting 30% of staff in the process.

Annalee Armstrong Apr 25, 2022 11:17am

Cambridge MA and Boston

Celgene backs next-gen oncolytic virus startup in $57M Series A

Jul 19, 2016 12:30pm